These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 34013968)

  • 1. International Forum on the Collection and Use of COVID-19 Convalescent Plasma: Protocols, Challenges and Lessons Learned: Summary.
    Al-Riyami AZ; Burnouf T; Yazer M; Triulzi D; Kumaş LT; Sağdur L; Pelit NB; Bazin R; Hindawi SI; Badawi MA; Patidar GK; Pandey HC; Chaurasia R; Fachini RM; Scuracchio P; Wendel S; Ang AL; Ong KH; Young P; Ihalainen J; Vierikko A; Qiu Y; Yang R; Xu H; Rahimi-Levene N; Shinar E; Izak M; Gonzalez CA; Ferrari DM; Cini PV; Aditya RN; Sharma RR; Sachdev S; Hans R; Lamba DS; Nissen-Meyer LSH; Devine DV; Lee CK; Leung JN; Hung IFN; Tiberghien P; Gallian P; Morel P; Al Maamari K; Al-Hinai Z; Vrielink H; So-Osman C; De Angelis V; Berti P; Ostuni A; Marano G; Nevessignsky MT; El Ekiaby M; Daly J; Hoad V; Kim S; van den Berg K; Vermeulen M; Glatt TN; Schäfer R; Reik R; Gammon R; Lopez M; Estcourt L; MacLennan S; Roberts D; Louw V; Dunbar N;
    Vox Sang; 2021 Nov; 116(10):1117-1135. PubMed ID: 34013968
    [No Abstract]   [Full Text] [Related]  

  • 2. Convalescent plasma for COVID-19 considerations.
    Adiwinata Pawitan J
    Transfus Apher Sci; 2021 Feb; 60(1):102927. PubMed ID: 32878733
    [No Abstract]   [Full Text] [Related]  

  • 3. Covid-19 convalescent plasma and SARS-CoV-2 viral variants.
    Joob B; Wiwanitkit V
    Transfus Clin Biol; 2021 Aug; 28(3):306. PubMed ID: 34116915
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of Convalescent Plasma in the Management of COVID-19.
    Dandachi D; Khalaf SA
    Mo Med; 2021; 118(2):118. PubMed ID: 33840851
    [No Abstract]   [Full Text] [Related]  

  • 5. How Safe Is COVID-19 Convalescent Plasma?
    Franchini M; Cruciani M
    Mayo Clin Proc; 2021 Aug; 96(8):2279-2281. PubMed ID: 34353475
    [No Abstract]   [Full Text] [Related]  

  • 6. Correspondence on 'CONVALESCENT plasma for COVID-19'.
    Mungmunpuntipantip R; Wiwanitkit V
    Eur J Clin Invest; 2021 Nov; 51(11):e13677. PubMed ID: 34487554
    [No Abstract]   [Full Text] [Related]  

  • 7. [COVID-19: blood sufficiency versus convalescent plasma?].
    Contreras M
    Rev Med Chil; 2020 Jun; 148(6):721-723. PubMed ID: 33480368
    [No Abstract]   [Full Text] [Related]  

  • 8. [Convalescent plasma therapy in COVID-19 patients].
    Ascencios L; Casa L
    Medicina (B Aires); 2021; 81(2):306. PubMed ID: 33906156
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19 convalescent plasma therapy and immunodeficiency.
    Mungmunpuntipantip R; Wiwanitkit V
    Transfus Clin Biol; 2021 Aug; 28(3):306-307. PubMed ID: 34116917
    [No Abstract]   [Full Text] [Related]  

  • 10. In Reply-How Safe Is COVID-19 Convalescent Plasma?
    Joyner MJ; Klompas AM; Klassen SA; Senefeld JW; Fairweather D; Wright RS; Carter RE
    Mayo Clin Proc; 2021 Aug; 96(8):2281-2282. PubMed ID: 34353476
    [No Abstract]   [Full Text] [Related]  

  • 11. Convalescent Plasma Therapy for COVID-19: Lessons from SARS-CoV, MERS-CoV, and H1N1 Infection.
    Hosseini P; Rahimi H; Najafabadi MM; Ghorbani A; Najafabadi SK; Faridzadeh A; Arabpour J; Khormali E; Deravi N
    Acta Med Indones; 2021 Jan; 53(1):86-95. PubMed ID: 33818411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Convalescent plasma for administration of passive antibodies against viral agents.
    Di Minno G; Mannucci PM; Ironside JW; Perno CF; Gürtler L; Aledort L
    Haematologica; 2020 Dec; 105(12):2710-2715. PubMed ID: 33256373
    [No Abstract]   [Full Text] [Related]  

  • 13. Implications of Coronavirus Disease 2019 (COVID-19) Antibody Dynamics for Immunity and Convalescent Plasma Therapy.
    Casadevall A; Joyner MJ; Pirofski LA
    Clin Infect Dis; 2021 Aug; 73(3):e540-e542. PubMed ID: 32805024
    [No Abstract]   [Full Text] [Related]  

  • 14. Convalescent plasma in patients hospitalised with COVID-19.
    Liu STH; Aberg JA
    Lancet; 2021 May; 397(10289):2024-2025. PubMed ID: 34000255
    [No Abstract]   [Full Text] [Related]  

  • 15. COVID-19 convalescent plasma therapy: hit fast, hit hard!
    Focosi D; Franchini M
    Vox Sang; 2021 Oct; 116(9):935-942. PubMed ID: 33794556
    [No Abstract]   [Full Text] [Related]  

  • 16. The Association Between Convalescent Plasma Treatment and Survival of Patients with COVID-19.
    Kuno T; Takahashi M; Egorova NN
    J Gen Intern Med; 2021 Aug; 36(8):2528-2531. PubMed ID: 33987794
    [No Abstract]   [Full Text] [Related]  

  • 17. COVID-19 convalescent plasma; time for "goal directed therapy"?
    Knudson CM; Jackson JB
    Transfusion; 2021 May; 61(5):1654-1656. PubMed ID: 33723852
    [No Abstract]   [Full Text] [Related]  

  • 18. Appropriate selection of convalescent plasma donors for COVID-19.
    Tedder RS; Semple MG
    Lancet Infect Dis; 2021 Feb; 21(2):168-169. PubMed ID: 32553190
    [No Abstract]   [Full Text] [Related]  

  • 19. Early and persistent viral clearance in COVID-19 patients treated with convalescent plasma.
    Franchini M; Glingani C; Bellani A; Cicorella N; Amadini A; De Donno G; Casari S
    Transfus Clin Biol; 2021 Aug; 28(3):309-310. PubMed ID: 33931305
    [No Abstract]   [Full Text] [Related]  

  • 20. (A Little) Clarity on Convalescent Plasma for Covid-19.
    Katz LM
    N Engl J Med; 2021 Feb; 384(7):666-668. PubMed ID: 33440086
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.